January 23, 2013 4:04pm EST
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE:OPK) announced today that it plans to sell
approximately $150 million aggregate principal amount of convertible
senior notes due 2033 (the "Notes") in a private offering. The Notes
will be OPKO's senior unsecured obligations and will rank equally with
all of OPKO's other existing and future senior unsecured debt. The
interest rate, conversion rate and other terms of the Notes will be
determined at the time of pricing of the offering. The planned offering
of Notes is subject to market conditions and other factors and no
assurance can be given that the offering will be completed.
OPKO intends to use the net proceeds from this offering for general
corporate purposes, including research and development expenses,
acceleration of clinical trials, acquisitions of new technologies or
businesses and other business opportunities.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities and shall not constitute
an offer, solicitation or sale in any jurisdiction in which such offer,
solicitation or sale would be unlawful. The Notes and the shares of OPKO
common stock issuable upon conversion of the Notes will not be
registered under the Securities Act of 1933, as amended (the "Securities
Act"), or the securities laws of any other jurisdiction, and may not be
offered or sold in the United States absent registration under the
Securities Act or an applicable exemption from registration requirements.
OPKO Health, Inc.
Steven D. Rubin or Juan F. Rodriguez,
Source: OPKO Health, Inc.
Released January 23, 2013
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page